Perricone Md Acne Relief Maximum Strength Clearing Treatment

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with acne vulgaris, providing therapeutic benefits in managing this dermatological condition.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. Initially, it is advised to start with one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

For new users, it is recommended to apply the product sparingly to one or two small affected areas during the first three days of treatment. If no discomfort is experienced, the user may then follow the previously mentioned dosing instructions. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to mitigate these effects.

Contraindications

The use of this product is contraindicated in patients who are currently using another topical acne medication, as this may lead to increased skin irritation and dryness. Additionally, if irritation occurs during use, the product should be discontinued. It is recommended to use only one topical acne medication at a time to minimize the risk of adverse effects.

Warnings and Precautions

For external use only. It is imperative that this product is applied solely to the skin and not ingested.

Healthcare professionals should advise patients to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Centre is recommended. Prompt action is crucial to ensure patient safety.

Side Effects

For external use only. Patients should be advised to avoid contact with eyes and mucous membranes. In the event of accidental contact, the affected area should be rinsed thoroughly with water. Adverse reactions associated with the use of this product have not been specifically detailed in clinical trials or postmarketing experiences. Therefore, healthcare providers should monitor patients for any unexpected reactions and report them as necessary.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Perricone Md Acne Relief Maximum Strength Clearing Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, medical assistance or contact with a Poison Control Centre is recommended immediately.

For the application of the product, it is suggested to begin with one application daily to minimize the risk of excessive skin drying. If necessary, the frequency may be gradually increased to two or three times daily, as directed by a healthcare professional. Should any bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

For new users, a sensitivity test is recommended. The product should be applied sparingly to one or two small affected areas during the first three days. If no discomfort is experienced, patients may proceed with the application as previously directed.

Geriatric Use

Elderly patients do not have specific geriatric use considerations, dosage adjustments, or safety concerns associated with the use of Perricone MD Acne Relief Maximum Strength Clearing Treatment as indicated in the provided drug insert. Therefore, healthcare providers may administer this treatment to geriatric patients without the need for modifications based on age-related factors. However, it is always prudent to monitor elderly patients for any unexpected reactions or side effects, as individual responses to treatment may vary.

Pregnancy

Safety during pregnancy has not been established for the use of this product. The use of salicylic acid is contraindicated in pregnancy due to the potential risk to the fetus. There is a risk of teratogenic effects associated with the use of salicylic acid during this period. Therefore, pregnant women should avoid using this product unless directed by a healthcare provider. It is essential for healthcare professionals to counsel women of childbearing potential regarding these risks and to consider alternative treatments when necessary.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product in lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial for healthcare professionals to document all findings and interventions thoroughly and to report any adverse events related to overdosage to the appropriate regulatory authorities.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of the product. These include skin irritation, dryness, and allergic reactions. Additional reports have documented cases of contact dermatitis and exacerbation of acne.

Rare instances of severe allergic reactions, including anaphylaxis, have been reported. Some patients have also experienced increased sensitivity to sunlight. Furthermore, reports of skin discoloration and changes in skin texture have been noted. The frequency of these adverse reactions is not known.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Centre immediately.

When using this product, it is important to inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Therefore, if irritation does occur, patients should be instructed to use only one topical acne medication at a time to minimize the risk of adverse effects.

Additionally, healthcare providers should counsel patients to rinse the product immediately with water if it comes into contact with their eyes to prevent irritation or injury.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or directed by a healthcare professional. In cases of bothersome dryness or peeling, it is advised to reduce the frequency to once a day or every other day.

Clinicians should counsel patients on the potential for skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is important to advise patients to use only one topical acne medication at a time to minimize irritation. Patients should also be instructed to rinse the medication from their eyes immediately if contact occurs and to keep the product out of reach of children. In the event of ingestion, medical assistance or contact with a Poison Control Centre is necessary.

Drug Information (PDF)

This file contains official product information for Perricone Md Acne Relief Maximum Strength Clearing Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)